德斯控股(08437.HK)完成配售1.2億股 淨籌2659.5萬港元
格隆匯 1 月 12日丨德斯控股(08437.HK)宣佈,配售事項的條件已達成,並已於2021年1月12日完成。配售代理根據配售協議的條款及條件,按每股配售股份0.225港元的配售價成功向不少於六名承配人配售全數1.20億股配售股份。
配售事項所得款項淨額約為2659.5萬港元。配售股份佔緊接配售事項完成前公司現有已發行股本約20%,以及公司經配發及發行配售股份擴大後的已發行股本約16.66%。
公司有意將配售事項所得款項淨額(a)約1200萬港元用作集團一般營運資金;(b)約900萬港元用於新產品,包括新護膚產品、抗疫產品及抗衰老產品之開發、品牌推廣、市場營銷及採購;及(c)約600萬港元用於發展及提升遠程醫療及網上預約。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.